Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Clinical trial results for Retatrutide are exceptionally promising
GLP-1 drugs, like Semaglutide, target only the GLP-1 receptor, which helps regulate blood sugar, slows digestion, and suppresses appetite
These include the treatment of prediabetes (the drug can delay the onset of symptoms), gestational diabetes (which some pregnant women develop), polycystic ovarian syndrome (the drug can help regular the menstrual cycle), and weight gain from the use of antipsychotic medicines
Furthermore, the potential for this therapeutically desirable property was not suggested from the measurement of acute cAMP responses in CHO-GLP-1R cells, a standard in vitro metric for GLP-1R agonist performance in drug development 23 , where the more insulinotropic compounds displayed reduced potency vs
This development is expected to broaden patient access and adherence to obesity treatments
US$ 20.40
US$ 24.25
US$ 22.45
US$ 29.35
US$ 27.53
